Skip to main content
Log in

Lamotrigine in Rett syndrome: Treatment experience from a pilot study

  • ORIGINAL CONTRIBUTION
  • Published:
European Child & Adolescent Psychiatry Aims and scope Submit manuscript

Abstract

This open pilot study was performed to evaluate the effect of Lamotrigine (LTG) in girls with Rett syndrome (RS) regarding seizure frequency, effect on gross motor dyspraxia and safety. Twelve girls with either the classical form of RS or the milder form fruste variants were included. The effect on epilepsy was evaluated as seizure frequency, motor performance (video comparison) and safety at clinical check up. The dosage of LTG was individualized and related to concomitant anti-epileptic drugs. Two of three girls with epilepsy responded relatively well to treatment, and for one of them even bad tantrums disappeared. LTG was useful in another four girls who became happier, more alert, more able to concentrate, and improved in contacting. Only mild adverse reactions as rash and tremor were seen. It is concluded that LTG could be worth trying as an adjunct in girls with RS, being aware of possible adverse reactions and no effect at all.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 19 March 1997 Accepted: 3 June 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stenbom, Y., Tonnby, B. & Hagberg, B. Lamotrigine in Rett syndrome: Treatment experience from a pilot study. European Child & Adolescent Psychiatry 7, 49–52 (1998). https://doi.org/10.1007/s007870050045

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s007870050045

Navigation